Kalkine has a fully transformed New Avatar.

Switch to Old version
1800-272-662
Shopping Cart 0
countryflagAU
Login

Perimeter Medical Imaging AI Inc

Healthcare US PYNKF

0.3604USD
0.01(2.97%)

Last update at 2026-03-10T19:57:00Z

Day Range

0.330.36
LowHigh

52 Week Range

0.541.50
LowHigh

Fundamentals

  • Previous Close 0.35
  • Market Cap52.93M
  • Volume150297
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-13.99414M
  • Revenue TTM0.63M
  • Revenue Per Share TTM0.01
  • Gross Profit TTM -0.73851M
  • Diluted EPS TTM-0.19

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -9.90611M -16.65177M -7.88597M -10.34269M -
Minority interest - - - - -
Net income -3.58598M -16.76208M -8.00301M -10.49865M -
Selling general administrative 5.45M 7.89M 8.84M 7.51M -
Selling and marketing expenses 4.84M 3.67M 0.12M 0.04M -
Gross profit 0.10M 0.00504M - - -
Reconciled depreciation 0.80M 0.09M 0.05M 0.05M -
Ebit -16.12131M -16.04838M -11.66809M -13.01917M -5.89451M
Ebitda -15.32045M -15.95455M -11.62052M -12.96733M -
Depreciation and amortization 0.80M 0.09M 0.05M 0.05M -
Non operating income net other - - - - -
Operating income -16.12131M -16.04838M -11.66809M -13.01917M -
Other operating expenses 16.25M 16.07M 10.06M 8.56M 0.31M
Interest expense 0.10M 0.11M 0.12M 0.16M 0.00000M
Tax provision 0.00000M 0.00000M 0.00000M 0.00000M -
Interest income - 0.01M 0.00690M 0.00464M -
Net interest income -0.10493M -0.10049M -1.72350M -4.61071M -
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense -6.32013M 0.11M 0.12M 0.16M -
Total revenue 0.13M 0.01M 0.00000M 0.00000M -
Total operating expenses 16.22M 16.06M 10.06M 8.56M -
Cost of revenue 0.03M 0.00630M - - -
Total other income expense net 6.22M -0.60339M 3.78M 2.68M -
Discontinued operations - - - - -
Net income from continuing ops -9.90611M -16.65177M -7.88597M -10.34269M -
Net income applicable to common shares - - -7.88597M -10.34269M -6.50451M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 34.60M 9.98M 13.16M 2.55M -
Intangible assets - - - - -
Earning assets - - - - -
Other current assets 1.04M 1.25M - - -
Total liab 8.49M 2.56M 2.40M 19.03M -
Total stockholder equity 26.11M 7.42M 10.76M -16.47321M -
Deferred long term liab - - - - -
Other current liab 7.79M 1.85M 1.21M 2.36M 2.17M
Common stock 80.84M 62.47M 48.50M 17.80M 13.54M
Capital stock 80.84M 62.47M 48.50M 17.80M -
Retained earnings -59.32298M -63.98144M -47.32967M -39.44370M -29.10102M
Other liab - - 0.27M 0.28M 0.42M
Good will - - - - -
Other assets - - - - -
Cash 28.44M 4.72M 10.03M 1.21M -
Cash and equivalents - - - - -
Total current liabilities 8.04M 2.15M 1.82M 18.54M 15.05M
Current deferred revenue 0.10M 0.11M 0.52M 0.14M -
Net debt -28.11337M -4.27884M -9.62432M 13.00M -
Short term debt 0.15M 0.18M 0.09M 14.01M -
Short long term debt 0.11M 0.13M 0.05M 13.99M -
Short long term debt total 0.33M 0.44M 0.40M 14.21M -
Other stockholder equity 6.64M 8.83M 9.40M 5.17M -
Property plant equipment - - 0.08M 0.07M 0.04M
Total current assets 31.50M 7.74M 13.07M 2.48M 2.90M
Long term investments - - - - -
Net tangible assets - - 10.76M -16.47703M -12.90771M
Short term investments 0.00000M 0.42M 1.67M 0.00000M -
Net receivables 1.98M 1.33M 0.60M 1.01M 0.85M
Long term debt 0.00965M 0.16M 0.29M 0.20M -
Inventory 0.04M 0.00649M - - -
Accounts payable - - 1.21M 2.03M 0.63M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -2.04453M 0.10M 0.18M - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - - -
Deferred long term asset charges - - - - -
Non current assets total 3.10M 2.25M 0.09M 0.07M -
Capital lease obligations 0.21M 0.15M 0.06M 0.02M -
Long term debt total - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -1.74879M -1.44806M 6.33M 6.33M 6.33M
Change to liabilities 0.00000M -0.90960M -0.16156M 1.06M 0.75M
Total cashflows from investing activities - - 7.24M -0.04695M -0.05385M
Net borrowings - - -0.14109M 1.11M -0.03076M
Total cash from financing activities 40.28M 10.06M 9.84M 5.20M -0.02976M
Change to operating activities - -0.48625M -0.51238M -0.05025M -0.02387M
Net income -9.90611M -16.65177M -7.88597M -10.34269M -6.50451M
Change in cash 24.72M -5.30512M 8.81M -0.63541M -4.17138M
Begin period cash flow 3.72M 10.03M 1.21M 1.85M -
End period cash flow 28.44M 4.72M 10.03M 1.21M 1.85M
Total cash from operating activities -11.86791M -13.91239M -8.26299M -5.78515M -4.08777M
Issuance of capital stock 38.14M 0.00000M 9.41M 4.08M -
Depreciation 0.80M 0.09M 0.05M 0.05M 0.03M
Other cashflows from investing activities - - - - -
Dividends paid - - - - -
Change to inventory -0.03785M -0.00649M - - -
Change to account receivables -0.07200M 0.27M -0.26346M 0.19M -0.17858M
Sale purchase of stock - - - - -
Other cashflows from financing activities 2.37M 10.26M 0.57M 1.83M -0.30615M
Change to netincome - - 0.50M 3.07M 1.84M
Capital expenditures 1.99M 2.12M 0.00000M 0.05M 0.05M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -0.22628M 0.41M -0.93740M 1.21M -
Stock based compensation 1.52M 3.13M 2.25M 1.32M -
Other non cash items -4.06044M -0.90003M -1.84445M 1.98M -
Free cash flow -13.85927M -16.03478M -8.26299M -5.83210M -

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
PYNKF
Perimeter Medical Imaging AI Inc		 0.01 2.97% 0.36 - - 81.69 2.80 83.68 -2.8952
ABT
Abbott Laboratories		 -2.1 1.86% 110.55 37.15 23.15 4.67 4.97 4.88 19.38
SYK
Stryker Corporation		 -7.27 1.99% 358.65 44.07 24.94 5.51 6.12 6.05 25.73
MDT
Medtronic PLC		 -1.45 1.59% 89.89 26.60 15.87 3.35 2.08 3.90 14.12
BSX
Boston Scientific Corp		 -1.94 2.70% 69.96 68.17 24.57 5.85 4.26 6.46 26.80

Reports Covered

Stock Research & News

View All

Profile

Perimeter Medical Imaging AI, Inc., a medical technology company, develops and commercializes advanced imaging tools that allow surgeons, radiologists, and pathologists to visualize microscopic tissue structures during a clinical procedure. The company offers an optical coherence tomography (OCT) imaging system provides clinicians with cross-sectional of tissues down to 2 mm dept. This OCT imaging system consists of S-series OCT and B-series OCT. It also offers ImgAssist, an artificial intelligence technology that enhances the efficiency of image review and be an additional powerful tool when combined with Perimeter OCT to aid physicians with real-time margin visualization and assessment to improve surgical outcomes for patients and reducing the likelihood of needing additional surgeries. In addition, the company offers proprietary image library and consumable specimen containers to hospitals and cancer surgery centers. The company was founded in 2013 and is headquartered in Toronto, Canada.

Perimeter Medical Imaging AI Inc

359 Eastern Avenue, Toronto, ON, Canada, M4M 1B7

Key Executives

Name Title Year Born
Mr. Jeremy Sobotta CEO, Pres & Director NA
Mr. Merle Thomas Boon Chief Operating Officer NA
Mr. Andrew Berkeley Co-Founder & Head of Bus. Devel. NA
Mr. Christopher K. Scott Chief Financial Officer 1970
Mr. Vladimir Pekar Head of AI Algorithm Devel. NA
Ms. Rochelle Keen Head of Clinical Research Programs NA
Mr. Steve Sapot Chief Commercial Officer NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.